The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Hyaluronidase 1500 I.U. Powder for Solution for Injection or Infusion

1500 international unit(s) Powder for solution for injection/infusion

Wockhardt UK LimitedPA1339/011/001

Main Information

Trade NameHyaluronidase 1500 I.U. Powder for Solution for Injection or Infusion
Active SubstancesHyaluronidase
Strength1500 international unit(s)
Dosage FormPowder for solution for injection/infusion
Licence HolderWockhardt UK Limited
Licence NumberPA1339/011/001

Group Information

ATC CodeB06AA Enzymes
B06AA03 hyaluronidase

Status

Authorised/WithdrawnAuthorised
Licence Issued22/03/1984
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back